BridgeBio Pharma, Inc. (BBIO)
81.05
-0.45
(-0.55%)
USD |
NASDAQ |
Aug 24, 16:00
80.04
-1.01
(-1.25%)
After-Hours: 20:00
BridgeBio Pharma Total Liabilities (Quarterly) : 3.723B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.723B |
| March 31, 2026 | 3.640B |
| December 31, 2025 | 3.013B |
| September 30, 2025 | 2.921B |
| June 30, 2025 | 2.859B |
| March 31, 2025 | 2.520B |
| December 31, 2024 | 2.377B |
| September 30, 2024 | 1.883B |
| June 30, 2024 | 1.876B |
| March 31, 2024 | 1.886B |
| December 31, 2023 | 1.889B |
| September 30, 2023 | 1.849B |
| June 30, 2023 | 1.853B |
| March 31, 2023 | 1.839B |
| December 31, 2022 | 1.868B |
| September 30, 2022 | 1.859B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.877B |
| March 31, 2022 | 1.854B |
| December 31, 2021 | 1.878B |
| September 30, 2021 | 1.517B |
| June 30, 2021 | 1.537B |
| March 31, 2021 | 1.481B |
| December 31, 2020 | 595.70M |
| September 30, 2020 | 569.31M |
| June 30, 2020 | 577.72M |
| March 31, 2020 | 537.73M |
| December 31, 2019 | 155.70M |
| September 30, 2019 | 116.26M |
| June 30, 2019 | 593.09M |
| March 31, 2019 | 569.76M |
| December 31, 2018 | 566.44M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Ionis Pharmaceuticals, Inc. | 2.555B |
| Pfizer Inc. | 115.64B |
| Vertex Pharmaceuticals, Inc. | 7.175B |
| BioMarin Pharmaceutical, Inc. | 5.402B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.217B |
| Shareholders Equity (Quarterly) | -2.515B |
| Debt to Equity Ratio | -1.353 |
| Current Ratio | 1.227 |
| Net Debt Paydown Yield | -1.44% |